STEREOTAXIS WKN: A1J09L ISIN: US85916J4094 Kürzel: RJR1 Forum: Aktien Thema: Hauptdiskussion
2,21 EUR
±0,00 %±0,00
22. Dec, 18:58:47 Uhr,
Lang & Schwarz
Kommentare 221
odi001,
10.01.2024 20:18 Uhr
0
https://cardiacrhythmnews.com/first-patients-treated-with-stereotaxis-robotically-navigated-magnetic-ablation-catheter/
odi001,
02.12.2023 15:31 Uhr
0
https://www.massdevice.com/first-cases-stereotaxis-robotic-magnetic-navigation/
odi001,
12.11.2023 20:29 Uhr
0
https://www.stck.pro/news-link/67018799
odi001,
22.08.2023 20:28 Uhr
1
https://www.insiderkauf.de/company/STXS-Stereotaxis
odi001,
11.08.2023 6:46 Uhr
1
https://seekingalpha.com/article/4627043-stereotaxis-inc-stxs-q2-2023-earnings-call-transcript?utm_source=stck.pro&utm_medium=referral
odi001,
10.08.2023 15:07 Uhr
1
https://www.benzinga.com/pressreleases/23/08/g33706048/stereotaxis-reports-2023-second-quarter-financial-results
odi001,
16.06.2023 5:19 Uhr
0
https://beststocks.com/stereotaxis-announces-firstinhuman-trial-for/
odi001,
19.05.2023 14:46 Uhr
0
https://www.globenewswire.com/news-release/2023/05/19/2672554/21634/en/Stereotaxis-and-Abbott-Announce-Global-Collaboration-Combining-Leading-Mapping-and-Robotic-Technologies-to-Improve-Treatment-of-Abnormal-Heart-Rhythms.html
Summer.76,
03.03.2023 17:12 Uhr
0
https://www.globenewswire.com/news-release/2023/03/03/2620292/21634/en/Stereotaxis-Reports-2022-Full-Year-Financial-Results.html
Summer.76,
20.12.2022 18:20 Uhr
0
https://finance.yahoo.com/news/corewell-health-grows-robotic-program-140400345.html
Summer.76,
10.11.2022 17:36 Uhr
0
https://www.globenewswire.com/news-release/2022/11/10/2553299/21634/en/Stereotaxis-Reports-2022-Third-Quarter-Financial-Results.html
Summer.76,
09.08.2022 15:32 Uhr
0
Stereotaxis Reports 2022 Second Quarter Financial Results
https://www.globenewswire.com/news-release/2022/08/09/2494993/21634/en/Stereotaxis-Reports-2022-Second-Quarter-Financial-Results.html
Summer.76,
02.08.2022 18:13 Uhr
0
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline
https://www.globenewswire.com/news-release/2022/08/02/2490493/0/en/Industry-Veterans-Join-Stereotaxis-Commercial-Leadership-Team-as-Company-Advances-Robust-Innovation-Pipeline.html
Summer.76,
11.07.2022 20:32 Uhr
0
Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter
https://www.globenewswire.com/news-release/2022/07/11/2477357/0/en/Stereotaxis-Announces-CE-Mark-Submission-for-Robotically-Navigated-MAGiC-Ablation-Catheter.html
Summer.76,
10.05.2022 15:39 Uhr
0
Stereotaxis GAAP EPS of -$0.06 beats by $0.01, revenue of $7M beats by $0.33M
https://seekingalpha.com/news/3835928-stereotaxis-gaap-eps-of--006-beats-by-001-revenue-of-7m-beats-by-033m
• Stereotaxis press release (NYSE:STXS): Q1 GAAP EPS of -$0.06 beats by $0.01.
• Revenue of $7M (-18.6% Y/Y) beats by $0.33M.
Summer.76,
10.05.2022 15:38 Uhr
0
Stereotaxis Reports 2022 First Quarter Financial Results
https://www.globenewswire.com/news-release/2022/05/10/2439801/21634/en/Stereotaxis-Reports-2022-First-Quarter-Financial-Results.html
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | MICROSTRATEGY Hauptdiskussion | ±0,00 % | |
| 2 | Brainchip Klassengruppe | ±0,00 % | |
| 3 | XIAOMI CORP. CL.B Hauptdiskussion | +0,10 % | |
| 4 | GEVO Hauptdiskussion | ±0,00 % | |
| 5 | IonQ | +17,62 % | |
| 6 | Dax Prognose | -0,40 % | |
| 7 | TESLA MOTORS Hauptdiskussion | +0,04 % | |
| 8 | CD PROJEKT Hauptdiskussion | +0,07 % | |
| 9 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
| 10 | Aktuelles zu Almonty Industries | ±0,00 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | MICROSTRATEGY Hauptdiskussion | ±0,00 % | |
| 2 | Brainchip Klassengruppe | ±0,00 % | |
| 3 | XIAOMI CORP. CL.B Hauptdiskussion | +0,10 % | |
| 4 | GEVO Hauptdiskussion | ±0,00 % | |
| 5 | IonQ | +17,62 % | |
| 6 | TESLA MOTORS Hauptdiskussion | +0,04 % | |
| 7 | CD PROJEKT Hauptdiskussion | +0,07 % | |
| 8 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
| 9 | Aktuelles zu Almonty Industries | ±0,00 % | |
| 10 | MicroStrategy | ±0,00 % | Alle Diskussionen |